Patent directory · USPTO A61K / A61P
Patents matching “CTOR”
756 pharma patents match "CTOR" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 756 pharmaceutical patents matching "CTOR" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11981912
Adeno associated virus vectors for the treatment of hunter disease
granted -
US 11976293
Optimized lentiviral vector for stem cell gene therapy of hemoglobinopathies
granted -
US 11974980
In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumors
granted -
US 11965166
Complement factor B (CFB) iRNA compositions and methods of use thereof
granted -
US 11964000
Cancer treatment methods using nanofiber stabilized growth factors
granted -
US 11965190
Vectors, genetically modified bacteria, and methods of making and using
granted -
US 11946065
Transgene cassettes, AAV vectors, and AAV viral vectors for expression of human codon-optimized CSTB
granted -
US 11926830
Modulators of Complement Factor B
granted -
US 11925675
Systemic delivery of adeno-associated virus vector expressing gamma-sarcoglycan and the treatment of muscular dystrophy
granted -
US 11918660
Viral vectors for cancer therapy
granted -
US 11890354
Activatable antibodies that bind epidermal growth factor receptor and methods thereof
granted -
US 11891436
Monoclonal antibodies to growth and differentiation factor 15 (GDF-15)
granted -
US 11879017
Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer
granted -
US 11859020
Insulin like growth factor binding protein bioactive peptide fragments
granted -
US 11851440
Modulators of eukaryotic initiation factor 2B, compositions and methods
granted -
US 11845959
Identification of factor that promotes human HSC self-renewal
granted -
US 11827713
Chimeric antibody immune effector cell engagers and methods of use thereof
granted -
US 11826464
Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device
granted -
US 11819517
Methods of using tumor infiltrating lymphocytes in double-refractory melanoma
granted -
US 11821008
Liver targeting adeno-associated viral vectors
granted -
US 11814641
Retroviral and lentiviral vectors
granted -
US 11813316
Lentiviral vector for treating hemoglobin disorders
granted -
US 11802292
Modified orthopoxvirus vectors
granted -
US 11779660
Viral vectors for cancer therapy
granted